Fatigue in adult patients with primary immune thrombocytopenia

European Journal of Haematology

Volumn 86, Issue 5, 2011, Pages 420-429

  Newton, Julia L ^a   Reese, Jessica A ^b   Watson, Shirley I ^c   Vesely, Sara K ^b   Bolton Maggs, Paula H B ^d   George, James N ^b   Terrell, Deirdra R ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c ITP Support Association   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Fatigue; Immune thrombocytopenia; ITP

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BLEEDING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; FATIGUE; FEMALE; GENDER; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; REGISTER; SOMNOLENCE; SPLENECTOMY; STANDING; SYMPTOMATOLOGY; THROMBOCYTE COUNT; UNITED KINGDOM; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OKLAHOMA; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUESTIONNAIRES; REGISTRIES; YOUNG ADULT;

EID: 79954419462     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01587.x     Document Type: Article

References (48)

1. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
2. British Committee for Standards in Haematology. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-96.
3. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions, and outcome criteria in immune thrombocytopenic purpura (ITP) in adults and children. Report from an international working group. Blood 2009;113:2386-93.
4. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168-86.
5. Cines DB, Blanchette VS. Medical progress: immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008.
6. Nugent DJ, McMillan R, Nichol JL, Slichter SJ. Pathogenesis of chronic immune thrombocytopenic purpura: increase platelet destruction and/or decreased platelet production. Br J Haematol 2009;146:585-96.
7. George JN. Platelets. Lancet 2000;355:1531-9.
8. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005;106:2244-51.
9. Mathias SD, Gao SK, Miller KL, et al. Impact of chronic immune thrombocytopenic purpura on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes 2008;6:13.
10. Snyder CF, Mathias SD, Cella D, et al. Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey. Curr Med Res Opin 2008;24:2767-76.
11. Ware JE, Kosinski M. SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1. Lincoln, RI: QualityMetric Inc., 2001.
12. McMillan R, Bussel JB, George JN, Lalla D, Nichol JL. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol 2008;83:150-4.
13. George JN, Mathias SD, Go RS, et al. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol 2008;144:409-15.
14. Goldblatt J, Taylor PJS, Lipman T, et al. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology 2002;122:1235-41.
15. Cauch-Dudek K, Abbey S, Stewart DE, et al. Fatigue in primary biliary cirrhosis. Gut 1998;43:705-10.
16. Huet PM, Deslauriers J, Tran A, et al. Impact of fatigue on the quality of life in patients with primary biliary cirrhosis. Am J Gastroenterol 2000;95:760-7.
17. Wolfe F, Michaud K. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24, 831 patients. J Rheumatol 2004;11:2115-20.
18. Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology 2006;45:885-9.
19. Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996;23:1407-17.
20. Barendregt PJ, Visser MRM, Smets EMA, et al. Fatigue in primary Sjogrens syndrome. Ann Rheum Dis 1998;57:291-5.
21. Venables PJW. Management of patients presenting with Sjogren's syndrome. Best Pract Res Clin Haematol 2006;20:791-807.
22. Venables PJW. Sjögren's syndrome. Best Pract Res Clin Haematol 2004;18:313-29.
23. Newton JL, Gibson GJ, Tomlinson M, Wilton K, Jones DEJ. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology 2006;44:91-8.
24. Newton JL, Hudson M, Tachtatzis P, et al. The population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis. Hepatology 2007;45:1496-505.
25. Newton JL, Pairman J, Sutcliffe K, Wilton K, Jones DE. A predictive model for fatigue and its etiologic associations in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2008;6:228-33.
26. Jones DEJ, Sutcliffe K, Pairman J, et al. An integrated care pathway improves quality of life in primary biliary cirrhosis. QJM 2008;101:535-43.
27. Jones DEJ, Newton JL. An open study of Modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis. Aliment Pharmacol Ther 2007;25:471-6.
28. Sarpatwari A, Watson SP, Erqou S, et al. Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP). Br J Haematol 2010;151:189-91.
29. Fisk J, Ritvo P, Ross L, et al. Measuring the functional impact of fatigue: initial validation of the Fatigue Impact Scale. Clin Infect Dis 1994;18(Suppl 1):S79-83.
30. Prince MI, James OFW, Holland NP, et al. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol 2000;32:368-73.
31. Jones DEJ, Bhala N, Burt JA, Goldblatt J, Newton JL. Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort. Gut 2006;55:536-41.
32. Newton JL, Jones DEJ, Brown A, Sheerin N. Fatigue in early renal disease. Br J Renal Med 2009;14:10-4.
33. Newton JL, Okonkwo O, Sutcliffe K, et al. Symptoms of autonomic dysfunction in chronic fatigue syndrome. Q J Med 2007;100:519-26.
34. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-5.
35. Johns MW. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep 1994;17:703-10.
36. Schrezenmaier C, Gehrking JA, Hines SM, et al. Evaluation of orthostatic hypotension: relationship of a new self-report instrument to laboratory-based measures. Mayo Clin Proc 2005;80:330-4.
37. Valdini AF, Steinhardt SI, Jaffe AS. Demographic correlates of fatigue in a university family health centre. Fam Pract 1987;4:103-7.
38. Dowsett EG, Ramsay AM, McCartney RA, Bell EJ. Myalgic encephalomyelitis - a persistent enteroviral infection? Postgrad Med J 1990;66:526-30.
39. Ho-Yen DO, McNamara I. General practitioners' experience of the chronic fatigue syndrome. Br J Gen Pract 1991;41:324-6.
40. Newton JL, Jones DE, Henderson E, et al. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 2008;57:807-13.
41. Legge H, Norton M, Newton JL. Fatigue is significant in vasovagal syncope and is associated with autonomic symptoms. Europace 2008;10:1095-101.
42. Kovacs L, Paprika D, Takacs R, et al. Cardiovascular autonomic dysfunction in primary Sjögren's syndrome. Rheumatology (Oxford) 2004;43:95-9.
43. Mandl T, Wollmer P, Manthorpe R, Jacobsson LT. Autonomic and orthostatic dysfunction in primary Sjögren's syndrome. J Rheumatol 2007;34:1869-74.
44. Newton JL, Hollingsworth KG, MacGowan G, et al. Impaired cardiovascular function in primary biliary cirrhosis. Am J Physiol (GI) 2010;298:G764-73.
45. Hollingsworth K, Jones DEJ, Taylor R, Blamire A, Newton JL. Impaired cardiovascular response to standing in chronic fatigue syndrome. EJCI (in press) 2010;40:608-15.
46. Guidry JA, George JN, Vesely SK, Kennison SM, Terrell DR. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol 2009;83:175-82.
47. Guidry JA, Watson SP, George JN, Vesely SK, Terrell DR. Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol 2009;83:497-8.
48. Jones DE, Gray JC, Newton JL. Perceived Fatigue is comparable between diseases. Q J Med 2009;102:617-24.